Extractions: level=6 length=2 scatter=0.648078 sval^2=0.648078 [ratio 1] (Parent: length=4 scatter=2.10815 sval^2=0.833164) (ratio 2.53029) This node's top (Node-61) This node's Contents This node's Principal Direction This node's Centroid ... 62 (sibling) 17 (-0.7071) 17 DLCL-0011 +02 18 ( 0.7071) 18 DLCL-0032 -13 This node's top (Node-61) This node's Contents This node's Principal Direction This node's Centroid ... 62 (sibling) This node's top (Node-61) This node's Contents This node's Principal Direction This node's Centroid ... 62 (sibling) This node's top (Node-61) This node's Contents This node's Principal Direction This node's Centroid ... 62 (sibling)
Extractions: level=2 length=27 scatter=19.0535 sval^2=2.44955 [ratio 7.77836] (Parent: length=51 scatter=44.0813 sval^2=5.77909) (ratio 7.62772) This node's top (Node-8) This node's Contents This node's Principal Direction This node's Centroid ... 16 (right child) This node's top (Node-8) This node's Contents This node's Principal Direction This node's Centroid ... 16 (right child) This node's top (Node-8) This node's Contents This node's Principal Direction This node's Centroid ... 16 (right child) This node's top (Node-8) This node's Contents This node's Principal Direction This node's Centroid ... 16 (right child)
Extractions: Sponsored Links What are you looking for? the entire directory only in Cholesterol_and_Other_Fats/Cerebrotendinous_Xanthomatosis Popular Categories Popular Searches Recent Categories Recent Searches ... Cholesterol and Other Fats : Cerebrotendinous Xanthomatosis Top Web Sites: Cerebrotendinous Xanthomatosis: CTX - Symptoms presented with this disease, the diagnosis and the treatment.
DiseaseSeek.com Cerebrotendinous_Xanthomatosis Conditions and Diseases Nutrition and Metabolism Disorders Cholesterol and OtherFats cerebrotendinous xanthomatosis Found 2 sites about Cerebrotendinous http://www.diseaseseek.com/categories/Health__Conditions_and_Diseases__Nutrition
Extractions: @import url(http://www.animationseek.com/style.css); Search Directory Forum Conditions and Diseases Nutrition and Metabolism Disorders Cholesterol and Other Fats Cerebrotendinous Xanthomatosis - Found 2 sites about Cerebrotendinous Xanthomatosis Cerebrotendinous Xanthomatosis profile http://www.bhj.org/journal/1997/3901_jan/case_180.htm
The Database Rejected This Transaction. GDB Object Name cytochrome P450, subfamily XXVII (sterol27hydroxylase, cerebrotendinous xanthomatosis). http://gdbwww.dkfz-heidelberg.de/gdb-bin/genera/genera/hgd/ObjectName/2467661?!s
Jacob Clarenbach, MD Clinical Studies. Sterol Kinetics in Patients with cerebrotendinous xanthomatosis;Clinical Studies on the Pharmacology of Ezetimibe (Zetia®); http://www8.utsouthwestern.edu/utsw/cda/dept27717/files/155371.html
MITOP Human - Entry Defects in CYP27 are the cause of cerebrotendinous xanthomatosis (CTX), a raresterol storage disorder characterized clinically by progressive neurologic http://mips.gsf.de/cgi-bin/proj/medgen/tohtml?h A39740
Birth Disorder Information Directory - X List of Sites. Xanthoma Tuberosum See BroadBetalipoproteinemia. XanthomatosisCerebrotendinous (Cerebral Cholesterinosis, Sterol 27-Hydroxylase Deficiency) http://www.bdid.com/defectx.htm
Extractions: HOME X-Linked Lymphoproliferative Disease X-Linked Mental Retardation X-Linked Progressive Combined Variable Immunodeficiency X-Linked Severe Combined Immunodeficiency Xanthelasmoidea Xanthinuria (Xanthic Urolithiasis) Xanthoma Tuberosum Xanthomatosis Cerebrotendinous (Cerebral Cholesterinosis, Sterol 27-Hydroxylase Deficiency) Xeroderma with Talipes and Enamel Defects Xerodermic Idiocy of De Sanctic and Cacchione XK (Aprosencephaly) Syndrome (Aprosencephaly Syndrome, Aprosencephaly-Stelencephaly Syndrome, Atelencephalic Microcephaly Syndrome, Garcia Lurie Syndrome) XLP XTC Syndrome (Moynahan's Syndrome III, Xeroderma with Talipes and Enamel Defects) XX Male Syndrome XXY XY Gonadal Agenesis Syndrome Xylitol Dehydrogenase Deficiency
NurseZone - On The Job - Nursing News - Cardiology Case Report Coronary heart disease in a patient with cerebrotendinousxanthomatosis Journal of Internal Medicine. Here, we present http://www.nursezonenews.com/
Extractions: June 01, 2004 Smoking habits and predictors of continued smoking in patients with acute coronary syndromes Journal of Advanced Nursing Conclusions: Smoking patients who do not participate in a heart rehabilitation programme may need extra help with smoking cessation. The findings may provide means of identifying patients in need of special intervention... Acute Escherichia coli endotoxaemia decreases the plasma L-arginine/asymmetrical dimethylarginine ratio in humans Clinical Science Acute inflammation impairs vascular function. Based on the association between endothelial dysfunction and plasma concentrations of L-arginine and the endogenous nitric oxide synthase inhibitor ADMA (asymmetrical dimethylarginine), we hypothesized that the ratio between L-arginine and ADMA could be affected by experimental inflammation... Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk American Journal of Clinical Nutrition Conclusion: Low plasma PLP concentrations are inversely related to major markers of inflammation and independently associated with increased CAD risk...
CNR-PFI UO FEDERICO Antonio Geriat., 1994, suppl. 4 1318; FEDERICO A, DOTTI MT, LORÈ F, NUTI N, CerebrotendinousXanthomatosis pathophysiological study on bone metabolism, J. Neurol. http://www.aging.cnr.it/uoe/uo2_071.htm
Extractions: Title of research Side effects of drugs on mitochondrial metabolism. In vitro studies on cell lines and in vivo on populations. Minor clinical signs on carriers for dismetabolic neurogenetic disorders. Keywords mitochondria lysosomes carrier dementias Aims Side effect of antidepressant, antiarrythmic, neuroleptic drugs on mitochondrial and lysosomal metabolism in vivo and in vitro. Side effect of chronic use in population studies. The neuropharmacological model will be used for the study of the biochemical pathogenesis of the neurometabolic diseases. Studies of atypical cases of neurometabolic diseases. Evidence of minor clinical signs in carriers of neurometabolic genetic diseases considered as a model of premature ageing. Scientific activity Scientific results Reference